No Data
No Data
Jazz Pharma Gains on Late-stage Trial Win for Cancer Drug
Jazz Pharmaceuticals' Zepzelca/Tecentriq Combo Regimen Can Potentially Delay Disease Progression, Extend Survival In Aggressive Form Of Lung Cancer
Berenberg Bank Remains a Hold on Roche Holding AG (RHHVF)
Roche Holding AG (RHHVF) Gets a Sell From J.P. Morgan
Roche Says Evrysdi Shows Motor Function Benefits in Mid-stage Study
Roche (RHHBY.US) dual-target new drug new indication approved in China.
The latest announcement on the official website of the China National Medical Products Administration (NMPA) reveals that Roche (RHHBY.US) Rituximab Injection has received approval for a new indication application.
No Data
No Data